Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02201563 : Minocycline Therapy for Management of Adverse Radiation Effects
PhasePhase 1
AgesMin: 18 Years Max: 90 Years
Eligibility
Inclusion Criteria:

- Age range: 18 - 90 years

- Males and females.

- Patients must have undergone cranial radiosurgery.

- MRI evidence supporting the diagnosis of ARE and/or surgical biopsy evidence of
necrosis without tumor at ?2 months before study entry.

- Karnofsky performance status of ?60,

- With or without evidence of progressive neurologic signs or symptoms appropriate to
the location of the ARE, and no previous bevacizumab therapy.

- With or without previous chemotherapy for their tumor.

- Routine laboratory study results with bilirubin ?1.5 times the upper limit of normal,
aspartate aminotransferase and/or alanine aminotransferase <2.5 times the upper limit
of normal, creatinine <2.0 times the upper limit of normal.

- Patients with a history of seizures will be required to be receiving anticonvulsant
therapy and to be seizure-free for ?1 week before study.

Exclusion Criteria:

- Significant mass effect requiring resection (as assessed by a clinical neurosurgeon)

- Known hypersensitivity to tetracyclines

- Women of childbearing age must be non-lactating and have a negative urine pregnancy
test (adequate birth control includes use of intra uterine device, or a barrier
method, e.g. condom, diaphragm). The results of animal studies indicate that
tetracyclines cross the placenta and are found in fetal tissues, having potentially
toxic effects on the developing fetus (often related to retardation of skeletal
development). Evidence of embryo toxicity has been noted in animals treated early in
pregnancy. Therefore pregnant women will not be allowed to participate in this study

- Female subjects on oral contraceptives

- Contraindication to undergo MRI

- Significant cardiopulmonary, renal or neurological co-morbidities

- Current diagnosis of major depression, substance abuse, or other psychiatric
disorders;
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02201563      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740